Literature DB >> 31368776

The quantitative neuroradiology initiative framework: application to dementia.

Olivia Goodkin1,2, Hugh Pemberton1,2,3, Sjoerd B Vos1,2,4,5, Ferran Prados1,6,7, Carole H Sudre8,9, James Moggridge2,4, M Jorge Cardoso8, Sebastien Ourselin8, Sotirios Bisdas2,4, Mark White10, Tarek Yousry2,4, John Thornton2,4, Frederik Barkhof1,2,4,6,11.   

Abstract

There are numerous challenges to identifying, developing and implementing quantitative techniques for use in clinical radiology, suggesting the need for a common translational pathway. We developed the quantitative neuroradiology initiative (QNI), as a model framework for the technical and clinical validation necessary to embed automated segmentation and other image quantification software into the clinical neuroradiology workflow. We hypothesize that quantification will support reporters with clinically relevant measures contextualized with normative data, increase the precision of longitudinal comparisons, and generate more consistent reporting across levels of radiologists' experience. The QNI framework comprises the following steps: (1) establishing an area of clinical need and identifying the appropriate proven imaging biomarker(s) for the disease in question; (2) developing a method for automated analysis of these biomarkers, by designing an algorithm and compiling reference data; (3) communicating the results via an intuitive and accessible quantitative report; (4) technically and clinically validating the proposed tool pre-use; (5) integrating the developed analysis pipeline into the clinical reporting workflow; and (6) performing in-use evaluation. We will use current radiology practice in dementia as an example, where radiologists have established visual rating scales to describe the degree and pattern of atrophy they detect. These can be helpful, but are somewhat subjective and coarse classifiers, suffering from floor and ceiling limitations. Meanwhile, several imaging biomarkers relevant to dementia diagnosis and management have been proposed in the literature; some clinically approved radiology software tools exist but in general, these have not undergone rigorous clinical validation in high volume or in tertiary dementia centres. The QNI framework aims to address this need. Quantitative image analysis is developing apace within the research domain. Translating quantitative techniques into the clinical setting presents significant challenges, which must be addressed to meet the increasing demand for accurate, timely and impactful clinical imaging services.

Entities:  

Mesh:

Year:  2019        PMID: 31368776      PMCID: PMC6732931          DOI: 10.1259/bjr.20190365

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  38 in total

1.  Metrology Standards for Quantitative Imaging Biomarkers.

Authors:  Daniel C Sullivan; Nancy A Obuchowski; Larry G Kessler; David L Raunig; Constantine Gatsonis; Erich P Huang; Marina Kondratovich; Lisa M McShane; Anthony P Reeves; Daniel P Barboriak; Alexander R Guimaraes; Richard L Wahl
Journal:  Radiology       Date:  2015-08-12       Impact factor: 11.105

Review 2.  Structural MRI.

Authors:  Mike P Wattjes
Journal:  Int Psychogeriatr       Date:  2011-09       Impact factor: 3.878

3.  Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.

Authors:  J B Pereira; L Cavallin; G Spulber; C Aguilar; P Mecocci; B Vellas; M Tsolaki; I Kłoszewska; H Soininen; C Spenger; D Aarsland; S Lovestone; A Simmons; L-O Wahlund; E Westman
Journal:  J Intern Med       Date:  2013-10-30       Impact factor: 8.989

Review 4.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

5.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Authors:  P Scheltens; D Leys; F Barkhof; D Huglo; H C Weinstein; P Vermersch; M Kuiper; M Steinling; E C Wolters; J Valk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

6.  Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  Davangere P Devanand; Xinhua Liu; Matthias H Tabert; Gnanavalli Pradhaban; Katrina Cuasay; Karen Bell; Mony J de Leon; Richard L Doty; Yaakov Stern; Gregory H Pelton
Journal:  Biol Psychiatry       Date:  2008-08-23       Impact factor: 13.382

7.  Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group.

Authors:  M W Vernooij; F B Pizzini; R Schmidt; M Smits; T A Yousry; N Bargallo; G B Frisoni; S Haller; F Barkhof
Journal:  Neuroradiology       Date:  2019-03-09       Impact factor: 2.804

8.  Computer-assisted prediction of clinical progression in the earliest stages of AD.

Authors:  Hanneke F M Rhodius-Meester; Hilkka Liedes; Juha Koikkalainen; Steffen Wolfsgruber; Nina Coll-Padros; Johannes Kornhuber; Oliver Peters; Frank Jessen; Luca Kleineidam; José Luis Molinuevo; Lorena Rami; Charlotte E Teunissen; Frederik Barkhof; Sietske A M Sikkes; Linda M P Wesselman; Rosalinde E R Slot; Sander C J Verfaillie; Philip Scheltens; Betty M Tijms; Jyrki Lötjönen; Wiesje M van der Flier
Journal:  Alzheimers Dement (Amst)       Date:  2018-10-08

9.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

10.  Voxel-wise deviations from healthy aging for the detection of region-specific atrophy.

Authors:  Stefan Klöppel; Shan Yang; Elias Kellner; Marco Reisert; Bernhard Heimbach; Horst Urbach; Jennifer Linn; Stefan Weidauer; Tamara Andres; Maximilian Bröse; Jacob Lahr; Niklas Lützen; Philipp T Meyer; Jessica Peter; Ahmed Abdulkadir; Sabine Hellwig; Karl Egger
Journal:  Neuroimage Clin       Date:  2018-09-19       Impact factor: 4.881

View more
  7 in total

1.  Advances in neurodegenerative and psychiatric imaging: introductory editorial.

Authors:  Amy L Kotsenas; Meike W Vernooij; John D Port
Journal:  Br J Radiol       Date:  2019-09       Impact factor: 3.039

2.  Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.

Authors:  Silvia Ingala; Ingrid S van Maurik; Daniele Altomare; Raphael Wurm; Ellen Dicks; Ronald A van Schijndel; Marissa Zwan; Femke Bouwman; Niki Schoonenboom; Leo Boelaarts; Gerwin Roks; Rob van Marum; Barbera van Harten; Inge van Uden; Jules Claus; Viktor Wottschel; Hugo Vrenken; Mike P Wattjes; Wiesje M van der Flier; Frederik Barkhof
Journal:  Eur Radiol       Date:  2022-05-31       Impact factor: 5.315

Review 3.  Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility.

Authors:  Sheena I Dev; Bradford C Dickerson; Alexandra Touroutoglou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study.

Authors:  Hugh G Pemberton; Olivia Goodkin; Ferran Prados; Ravi K Das; Sjoerd B Vos; James Moggridge; William Coath; Elizabeth Gordon; Ryan Barrett; Anne Schmitt; Hefina Whiteley-Jones; Christian Burd; Mike P Wattjes; Sven Haller; Meike W Vernooij; Lorna Harper; Nick C Fox; Ross W Paterson; Jonathan M Schott; Sotirios Bisdas; Mark White; Sebastien Ourselin; John S Thornton; Tarek A Yousry; M Jorge Cardoso; Frederik Barkhof
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

5.  Comparing two artificial intelligence software packages for normative brain volumetry in memory clinic imaging.

Authors:  Jacob J Visser; Rebecca M E Steketee; Lara A M Zaki; Meike W Vernooij; Marion Smits; Christine Tolman; Janne M Papma
Journal:  Neuroradiology       Date:  2022-01-15       Impact factor: 2.995

Review 6.  Convolutional Neural Network Techniques for Brain Tumor Classification (from 2015 to 2022): Review, Challenges, and Future Perspectives.

Authors:  Yuting Xie; Fulvio Zaccagna; Leonardo Rundo; Claudia Testa; Raffaele Agati; Raffaele Lodi; David Neil Manners; Caterina Tonon
Journal:  Diagnostics (Basel)       Date:  2022-07-31

Review 7.  Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review.

Authors:  Hugh G Pemberton; Lara A M Zaki; Olivia Goodkin; Ravi K Das; Rebecca M E Steketee; Frederik Barkhof; Meike W Vernooij
Journal:  Neuroradiology       Date:  2021-09-03       Impact factor: 2.804

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.